Function: Adenylyltransferase mediating the addition of adenosine 5'-monophosphate (AMP) to specific residues of target proteins.
KEGG: dre:334648
UniGene: Dr.81867
FICD (FIC domain-containing protein) is an adenylyltransferase that mediates the addition and removal of adenosine 5'-monophosphate (AMP) to specific residues of target proteins, a process called AMPylation and de-AMPylation. In zebrafish (Danio rerio), the ficd gene encodes a 449 amino acid protein that functions in various cellular processes .
The primary functions of FICD include:
Regulation of protein folding in the endoplasmic reticulum (ER)
Modulation of BiP/GRP78 chaperone activity through AMPylation
Participation in cellular stress responses
Potential roles in immune function regulation
FICD acts bi-functionally; it can both AMPylate and de-AMPylate target proteins, with the enzyme's activity state determined by specific residues like E234 . This dual functionality allows for precise regulation of target protein activity in response to cellular conditions.
Zebrafish FICD contains several critical structural elements that determine its function:
The core FIC domain with the conserved HPFxxGNGR motif essential for AMPylation activity
A highly conserved region TLLFATTEY (aa 428-436) important for protein function
A critical glutamic acid residue (E234) that regulates the switch between AMPylation and de-AMPylation activities
The structural organization of FICD allows it to function as a molecular switch. According to research, the positioning of the E234-containing helix is crucial - when engaged in the active site, it blocks AMPylation and favors de-AMPylation. When disengaged, it promotes AMPylation . This conformational switching may be coupled to the burden of unfolded proteins in the ER, forming a regulatory mechanism that responds to cellular stress conditions.
Zebrafish FICD interacts with several proteins as part of its functional network. According to STRING interaction database analysis, the following proteins show significant interactions :
| Protein Partner | Function | Interaction Score |
|---|---|---|
| hspa5 | Immunoglobulin binding protein; Heat shock protein 70 family member | 0.894 |
| ankrd45 | Ankyrin repeat domain 45 | 0.833 |
| oat | Ornithine aminotransferase | 0.664 |
| rag2 | V(D)J recombination-activating protein 2 | 0.560 |
| plagl2 | Pleiomorphic adenoma gene-like 2 | 0.558 |
| ripk4 | Receptor-interacting serine-threonine kinase 4 | 0.558 |
| psph | Phosphoserine phosphatase | 0.556 |
| rag1 | V(D)J recombination-activating protein 1 | 0.556 |
| zic1 | ZIC family member 1 | 0.534 |
The strongest interaction is with hspa5 (BiP/GRP78), a major ER chaperone that is a primary target of FICD-mediated AMPylation . This interaction is particularly significant as BiP AMPylation affects protein folding and the unfolded protein response in the ER.
Studying FICD-mediated AMPylation in zebrafish requires specialized techniques. Based on current research approaches, the following methodologies have proven effective:
In vitro AMPylation assays:
Fluorescence polarization assays using fluorescent ATP analogs such as N6-(6-aminohexyl)-ATP-5-FAM to monitor AMPylation activity
Autoradiography with radioactively labeled ATP to visualize AMPylation of target proteins
Mass spectrometry analysis to identify modified residues and quantify AMPylation levels
In vivo approaches:
Generation of transgenic zebrafish lines expressing wild-type or mutant FICD
CRISPR-Cas9 gene editing to create FICD knockout or point mutations
Whole-mount in situ hybridization to visualize FICD expression patterns during development
Protein profiling throughout zebrafish embryogenesis using quantitative mass spectrometry
For recombinant protein studies:
Expression in bacterial systems (e.g., E. coli BL21 T7 Express cells)
Purification using affinity chromatography (GST-tag or His-tag)
Quality control via SDS-PAGE and Western blotting
A combination of these approaches provides comprehensive insights into FICD function and regulation in zebrafish.
The E234G mutation drastically alters FICD enzymatic activity by locking the enzyme in a constitutively AMPylating mode . This mutation has significant experimental implications:
Biochemical effects:
Wild-type FICD predominantly exhibits de-AMPylation activity in vitro
E234G mutation converts FICD into a constitutive AMPylase
The mutation prevents the E234 side chain from engaging with the active site, eliminating the regulatory switching mechanism
Experimental applications:
E234G mutants serve as valuable tools for studying AMPylation-specific effects
They allow researchers to bypass the natural regulatory mechanisms controlling FICD activity
The mutant can be used to identify novel AMPylation targets
Research protocol considerations:
When using FICD E234G in experiments, researchers should:
Include wild-type controls to compare natural vs. constitutive AMPylation
Consider the physiological relevance of increased AMPylation activity
Monitor potential off-target effects due to hyperactive AMPylation
Use site-directed mutagenesis to generate the E234G variant in expression constructs
As noted in research: "In vitro, the two forms of FICD, wildtype and E234G, represent the extremes of two opposing enzymatic activities... the E234G mutation locks FICD in a constitutively AMPylating mode" .
Production of functional recombinant zebrafish FICD presents several technical challenges that researchers need to address:
Expression system selection:
Bacterial systems may lack proper post-translational modifications
Mammalian expression systems better preserve native protein folding but have lower yields
Insect cell systems balance yield and post-translational modifications
Protein solubility and stability:
FICD contains hydrophobic regions that can reduce solubility
Special buffer considerations are needed (typically containing DTT or other reducing agents)
Storage recommendations include 50% glycerol and avoiding repeated freeze-thaw cycles
Purification protocol optimization:
Based on published protocols , effective purification requires:
Lysis in buffer containing 50 mM Tris-HCl pH 7.5, 500 mM NaCl, 1 mM MgCl₂, 2 mM DTT
Multiple washing steps with buffers containing varying concentrations of salt and detergent
Elution with glutathione for GST-tagged proteins
Optional tag removal using TEV protease
Size-exclusion chromatography for highest purity
Quality control:
Verification of enzymatic activity using fluorescence polarization assays
Confirmation of proper folding by circular dichroism
Assessment of protein homogeneity by dynamic light scattering
Adhering to these technical considerations significantly improves the likelihood of obtaining functionally active recombinant zebrafish FICD.
Zebrafish FICD serves as an excellent model for studying ER stress responses due to its conserved role in regulating BiP chaperone activity. Research approaches include:
Experimental design strategies:
Genetic manipulation approaches:
Generate transgenic zebrafish lines with fluorescently tagged FICD to monitor localization during stress
Create conditional FICD knockout/knockdown lines using CRISPR-Cas9 or morpholinos
Introduce point mutations (e.g., E234G) to alter FICD activity
ER stress induction protocols:
Chemical inducers: tunicamycin, thapsigargin, or DTT
Heat shock protocols
Hypoxia exposure
Expression of misfolding-prone proteins
Readouts for ER stress responses:
Quantification of BiP AMPylation levels via mass spectrometry
Monitoring unfolded protein response (UPR) gene expression
Assessing cell survival under stress conditions
Visualization of ER morphology changes
The bidirectional activity of FICD (AMPylation/de-AMPylation) serves as a regulatory mechanism that responds to the burden of unfolded proteins in the ER . When this burden is high, FICD predominantly performs de-AMPylation of BiP, enhancing its chaperone activity to handle increased folding demands. Conversely, when unfolded protein burden is low, FICD switches to AMPylation, inactivating BiP.
This system represents a rapid post-translational mechanism for modulating ER chaperone capacity without requiring new protein synthesis, making it an ideal model for studying adaptive stress responses.
The relationship between FICD and immune function in zebrafish is multifaceted, involving several potential mechanisms:
FICD-RAG protein interactions:
STRING interaction data shows connections between FICD and RAG1/RAG2 proteins with interaction scores of 0.556 and 0.560 respectively
RAG proteins are critical for V(D)J recombination in developing lymphocytes
This connection suggests FICD may influence adaptive immune development
Evolutionary significance:
Research on zebrafish has demonstrated RAG-mediated recombination in oocytes, supporting the theory that RAG may have evolved from a transposase that invaded germ cells of ancient species before becoming dedicated to lymphocyte recombination
FICD's FIC domain is conserved from bacteria to humans, suggesting ancient evolutionary origins potentially related to immune function
Experimental approaches to study this relationship:
Transcriptomic analysis:
Compare FICD and immune gene expression across developmental stages
Assess changes in FICD expression during immune challenges
Immune challenge studies:
Evaluate FICD expression and activity during viral or bacterial infection
Test if FICD knockdown affects zebrafish survival during immune challenges
Examine immune cell development in FICD-deficient zebrafish
Recombinant protein studies:
Test if recombinant FICD can AMPylate immune-related proteins
Investigate if immune stimulation alters FICD enzymatic preferences
Evidence suggests that administration of recombinant immune proteins like IFN1 can protect zebrafish from viral infections , highlighting the importance of recombinant protein studies in understanding immune function. Similar approaches could be applied to investigate FICD's role in immunity.
Recent research has begun to uncover correlations between FICD mutations and phenotypic changes, providing insights for zebrafish research:
Human FICD mutations and phenotypes:
A recent study identified a de novo missense variant (c.1295C>T p.Ala432Val) in the FICD gene in a patient with a complex clinical profile including:
Borderline intellectual functioning
Acanthosis
Abdominal muscle hypotonia
Anxiety and depression
Obesity
This mutation occurs in the highly conserved TLLFATTEY region (aa 428-436), suggesting potential impacts on protein function.
Translational research in zebrafish:
To investigate similar mutations in zebrafish, researchers could employ:
CRISPR-Cas9 gene editing to introduce equivalent mutations in the zebrafish ficd gene
Phenotypic analysis pipeline:
Behavioral tests for neurological and anxiety phenotypes
Histological examination of muscle development
Metabolic assessments for obesity-related phenotypes
Optic nerve evaluation
Stress response testing
Molecular characterization:
In vitro enzymatic activity assays comparing wild-type and mutant FICD
Protein interaction studies to identify altered binding partners
Structural analysis to determine effects on protein conformation
Rescue experiments:
Test if wild-type human FICD can rescue zebrafish mutant phenotypes
Evaluate tissue-specific rescue to identify critical FICD action sites
This translational approach allows researchers to validate findings from human studies in a tractable model organism and elucidate the mechanisms underlying FICD-associated phenotypes.
Studying the temporal dynamics of FICD activity during zebrafish development requires sophisticated methodological approaches:
Embryonic expression profiling:
Protein profiling throughout embryogenesis using quantitative mass spectrometry can identify FICD expression patterns
Comparison with transcriptomics and translatomics datasets provides insights into post-transcriptional regulation
Whole-mount in situ hybridization can visualize spatial expression patterns at different developmental stages
Real-time activity monitoring:
Biosensor development:
FRET-based biosensors that change conformation upon AMPylation
Fluorescently labeled substrates that change localization when modified
Split-luciferase reporters that assemble upon AMPylation events
Live imaging approaches:
Two-photon microscopy for deep tissue imaging in developing embryos
Light-sheet microscopy for whole-embryo visualization with minimal phototoxicity
Time-lapse confocal microscopy for subcellular resolution
Inducible systems for temporal control:
Heat-shock promoter-driven FICD expression
Chemically-inducible expression systems (e.g., Tet-On/Off)
Optogenetic control of FICD activity or expression
Integration with developmental staging:
Correlate FICD activity with key developmental milestones such as:
Maternal-to-zygotic transition (MZT)
Gastrulation
Organogenesis
Immune system development
Research has shown that proteins are generally more stable than RNAs during the MZT in zebrafish , suggesting post-translational modifications like AMPylation may play important roles during early development when transcriptional programs are changing rapidly.